Acticor Biotech R&D and Labs
.jpg)
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.
Founded Date:
2010-01-01
Estimated Revenue:
$1M to $10M
Total Funding:
$33 202 489
Last Funding Type:
Series B
Headquarters:
Paris, Ile-de-France, France
Funding Status:
Early Stage Venture
Last Funding Date:
2019-11-06